Biotech company gets millions for the development of drug against hearing loss

The new biotech company Hoba Therapeutics, which is developing a potential pain treatment, is hoping the drug will be effective as a medical treatment for hearing loss. The company has received a grant from the Danish Innovation Fund to continue its work in this area.

Photo: Niels Christensen/Politiken/Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles